HEALTHMay 28 · 07:07 UTCENGADGET[email protected] (Mariella Moon)

Samsung is testing Galaxy Watch 8 to prevent muscle loss on GLP-1s like Ozempic

Samsung is collaborating with diabetes experts at Massachusetts General Hospital to test the Galaxy Watch 8's ability to prevent muscle loss in patients using GLP-1 medications like Ozempic. The study aims to leverage wearable technology to address a known side effect of these drugs.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

SamsungorganizationMassachusetts General HospitalorganizationGalaxy Watch 8topicGLP-1stopicOzempictopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 21 · 21:02 UTC
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
HEALTHMay 20 · 18:00 UTC
STAT+: Scientists track cellular disruptions that lead to type 1 diabetes
HEALTHMay 7 · 10:11 UTC
Scientists discover why Ozempic works better for some people
HEALTHApr 15 · 13:50 UTC
Doctor warns wearable fitness trackers can backfire, despite Rory McIlroy's success
HEALTHMay 21 · 13:02 UTC
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
HEALTHMay 14 · 11:00 UTC
Experimental obesity drug outperforms traditional weight-loss treatments in early research